CME Group Inc., US12572Q1058

TD Cowen sets USD 300.00 target for CME Group stock

Published on 10/13/2026 at 16:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CME Group reports before market open on October 21, 2026. CME Group stock costs EUR 247.73 on October 13, 2026 at 4:35 p.m. CEST.

Analyst target and reporting date

  • TD Cowen lifted its CME Group target to USD 300.00 on October 5, 2026.
  • CME Group is scheduled to report third-quarter results on October 21, 2026.
  • CME Group stock costs EUR 247.73 at Lang & Schwarz on October 13, 2026 at 4:35 p.m. CEST.
  • The stock had a price-to-earnings ratio of 23.48 and a market capitalization of USD 99.7 billion.
Redaktionelles Foto eines aktiven Börsenparketts mit riesiger Kurstafel und Händlern
CME Group Inc. Börsen-Editorial mit Händlern und riesigen Chart-Displays, ISIN US12572Q1058 im aktiven Handelsgeschehen, Illustration mit AI erstellt.

TD Cowen raised its CME Group price target from USD 292.00 to USD 300.00 while maintaining a Buy rating in a report published on October 5, 2026, according to Investing.com. Against the Nasdaq quote of USD 277.28 on October 13, 2026, the new target lies 8.19 percent above the US share price. CME Group stock was at EUR 247.73 at Lang & Schwarz on October 13, 2026 at 4:35 p.m. CEST.

Results arrive October 21

CME Group is scheduled to publish third-quarter 2026 results before the US market opens on October 21, 2026. Zacks lists that date as a confirmed earnings release and gives a consensus estimate of USD 2.96 for earnings per share for the quarter ending September 2026. The date places the next financial update within eight days of the market snapshot.

Trading range remains wide

The Nasdaq-listed stock traded at USD 277.28 on October 13, 2026 at 10:44 a.m. ET. Its 52-week range was USD 218.31 to USD 329.16, putting the quote USD 51.88 below the high and USD 58.97 above the low. The market capitalization was USD 99.7 billion, while volume stood at 224,059 shares against an average volume of 2,038,017 shares.

The range gives the target discussion a clear market setting. The USD 300.00 TD Cowen objective sits below the 52-week high of USD 329.16, while the current Nasdaq quote remains above the midpoint of the yearly range. The euro quotation is a separate Lang & Schwarz market view and is not combined with the US dollar figures.

Valuation before the report

CME Group carried a price-to-earnings ratio of 23.48 and a trailing dividend yield of 4.00 percent on October 13, 2026. The company operates derivatives marketplaces covering interest rates, equity indexes, foreign exchange, agriculture, energy and metals, while also providing clearing and market-data services.

MarketBeat lists a consensus estimate of USD 2.98 in earnings per share and USD 1.71 billion in revenue for the third quarter of 2026. Those estimates give the October 21 release a defined benchmark for the next market reaction.

Comparison with peers

CME Group Inc.: P/E 23.48, market capitalization USD 99.7 billion

Intercontinental Exchange (NYSE, USD): plus 0.21 percent, P/E 22.29, market capitalization USD 88.6 billion

Nasdaq, Inc. (Nasdaq, USD): minus 0.77 percent, P/E 27.28, market capitalization USD 52.3 billion

Price and investor calendar

CME Group stock was at EUR 247.73 at Lang & Schwarz on October 13, 2026 at 4:35 p.m. CEST. The next scheduled financial date is October 21, 2026, when the company is expected to report third-quarter results.

The further course of trading is shown by the continuously updated real-time quote of CME Group stock.

CME Group stock data

  • Company: CME Group Inc.
  • ISIN: US12572Q1058
  • WKN: A0MW32
  • Ticker: CME
  • Primary exchange: NASDAQ
  • Price Lang & Schwarz (as of October 13, 2026, 4:35 p.m. CEST): EUR 247.73
  • Market capitalization: USD 99.7 billion (as of October 13, 2026)
  • 52-week range: USD 218.31-329.16 (as of October 13, 2026)
  • Sector / Industry: Financial Services / Financial - Data & Stock Exchanges
  • Index membership: S&P 500
  • Next earnings date: October 21, 2026

More news and analyses on CME Group stock

Disclaimer...

en | US12572Q1058 | CME GROUP INC. | boerse | 70316223 | bgmi